StocksGossamer Bio IncGOSS

GOSS

Gossamer Bio Inc

7.46 -0.36 (-4.60%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
7.44
B
7.48

Overview

Prev Close7.46
Day's Range 7.34 - 7.74
52 Week Range 6.25 - 14.26
Average Volume (3m)843.85K
1-Year Return-17.39%
Beta1.0374
Market Cap603.05M
P/E Ratio
Revenue0
EPS-3.1105
Dividend (Yield) (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Industry Pharmaceuticals Major
CEO Faheem Hasnain
Employees 185

FINANCIAL SUMMARY

For the quarter ended 31/3/2022, Gossamer Bio Inc's revenues decreased by NaN and amounted to 0.00. Net income decreased by 2.67% to -57.79M. Net assets decreased by 75.17% to 30.16M and EPS decreased from -0.74 to -0.76.
GOSS's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
N/A
Operating Margin
N/A
Return On Investment
116.90%
06/21
09/21
12/21
03/22
Total Revenue
0
0
0
0
Gross Profit
-1.3M
-1.31M
-1.28M
-1.1M
Operating Income
-55.58M
-55.65M
-51.65M
-54.32M
Net Income
-59.83M
-60.25M
-56.28M
-57.79M